213 related articles for article (PubMed ID: 14650931)
1. Production of high-quality marketing applications: strategies for biotechnology companies working with contract research organizations.
Hecker SJ; Preston C; Foote M
Biotechnol Annu Rev; 2003; 9():269-77. PubMed ID: 14650931
[TBL] [Abstract][Full Text] [Related]
2. Contract manufacturers add contract design to their services.
Resnick E
Med Device Technol; 2007; 18(7):38-9. PubMed ID: 18075134
[TBL] [Abstract][Full Text] [Related]
3. Managing strategic outsourcing.
Hogan J
Med Device Technol; 2004 Dec; 15(10):12-3. PubMed ID: 16225276
[TBL] [Abstract][Full Text] [Related]
4. Outsourcing to China.
Liu J
Med Device Technol; 2004 Dec; 15(10):15-6. PubMed ID: 16225277
[TBL] [Abstract][Full Text] [Related]
5. Outsourcing manufacturing.
Strauss L; Geimer H
Med Device Technol; 2001 Dec; 12(10):10-3. PubMed ID: 15966137
[TBL] [Abstract][Full Text] [Related]
6. Clinical trials integrity: a CRO perspective.
Beach JE
Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
[TBL] [Abstract][Full Text] [Related]
7. Outsourcing for product success and restful nights.
Hale D
Med Device Technol; 2008; 19(7):32, 34-5. PubMed ID: 19133626
[TBL] [Abstract][Full Text] [Related]
8. Outsourcing to win.
Fink P; Skeen J
Med Device Technol; 2007; 18(7):23-4. PubMed ID: 18075130
[TBL] [Abstract][Full Text] [Related]
9. Supplying the health-care explosion.
Bienias T
Med Device Technol; 2001 Dec; 12(10):14-5. PubMed ID: 15966138
[No Abstract] [Full Text] [Related]
10. Tuft's report backs FDA fast-track, but post-marketing concerns loom.
Vastag B
Nat Biotechnol; 2006 May; 24(5):478. PubMed ID: 16680113
[No Abstract] [Full Text] [Related]
11. Brokering knowledge in biosciences with InnoCentive. Interview by Semahat S. Demir.
Hussein A
IEEE Eng Med Biol Mag; 2003; 22(4):26-7. PubMed ID: 14515687
[No Abstract] [Full Text] [Related]
12. The proposed rule for U.S. clinical trial registration and results submission.
Zarin DA; Tse T; Sheehan J
N Engl J Med; 2015 Jan; 372(2):174-80. PubMed ID: 25539444
[No Abstract] [Full Text] [Related]
13. Strategic drivers of contract manufacturing: Part II, The practice.
Tomlinson G; Geimer H
Med Device Technol; 2003; 14(1):38-41. PubMed ID: 12974125
[TBL] [Abstract][Full Text] [Related]
14. The power of many.
Sansom C
Nat Biotechnol; 2011 Mar; 29(3):201-3. PubMed ID: 21390017
[No Abstract] [Full Text] [Related]
15. How to achieve high-mix, low-volume manufacturing success.
Allan T
Med Device Technol; 2007; 18(7):40-1. PubMed ID: 18075135
[TBL] [Abstract][Full Text] [Related]
16. [Scientific advice by the nationally competent authority and by the EMEA on the conduct of clinical trials].
Dejas-Eckertz P; Schäffner G
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Apr; 48(4):423-8. PubMed ID: 15830253
[TBL] [Abstract][Full Text] [Related]
17. Globalization of biotechnology and the public health challenges accompanying it.
Malinowski MJ
Albany Law Rev; 1996; 60(1):119-69. PubMed ID: 10170488
[No Abstract] [Full Text] [Related]
18. Characteristics of orphan drug applications that fail to achieve marketing approval in the USA.
Heemstra HE; Leufkens HG; Rodgers RP; Xu K; Voordouw BC; Braun MM
Drug Discov Today; 2011 Jan; 16(1-2):73-80. PubMed ID: 21094692
[TBL] [Abstract][Full Text] [Related]
19. Relocating abroad. FDA sends staff overseas to help monitor imports.
Lee J
Mod Healthc; 2011 Oct; 41(43):32. PubMed ID: 22111150
[No Abstract] [Full Text] [Related]
20. Biopharma CRO industry in China: landscape and opportunities.
Xia C; Gautam A
Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
